Related references
Note: Only part of the references are listed.Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
Christoph U. Correll et al.
SCHIZOPHRENIA (2022)
Characteristics and definitions of ultra-treatment-resistant schizophrenia - A systematic review and meta-analysis
Mattia Campana et al.
SCHIZOPHRENIA RESEARCH (2021)
Brain insulin action: Implications for the treatment of schizophrenia
Sri Mahavir Agarwal et al.
NEUROPHARMACOLOGY (2020)
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort
G. Fond et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)
How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials
Myrto T. Samara et al.
SCHIZOPHRENIA BULLETIN (2019)
Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics A Systematic Review and Meta-analysis of Cohort Studies
Takahiro Masuda et al.
JAMA PSYCHIATRY (2019)
Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months
H. Luckhoff et al.
SCHIZOPHRENIA RESEARCH (2019)
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016
Fiona J. Charlson et al.
SCHIZOPHRENIA BULLETIN (2018)
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
Alex T. Raben et al.
FRONTIERS IN NEUROSCIENCE (2018)
PharmGKB summary: clozapine pathway, pharmacokinetics
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2018)
Predictors of Nonhospitalization and Functional Response in Clozapine Treatment: A Nationwide, Population-Based Cohort Study
Ole Kohler-Forsberg et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis
Dan Siskind et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Predicting Weight Gain in Patients Treated With Clozapine The Role of Sex, Body Mass Index, and Smoking
Sue Lynn Lau et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Leptin reverses corticosterone-induced inhibition of neural stem cell proliferation through activating the NR2B subunits of NMDA receptors
Wen-Zhu Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics
Siti Norsyuhada Roffeei et al.
PHARMACOGENOMICS (2014)
Serum leptin and its relationship with psychopathology in schizophrenia
Milawaty Nurjono et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2014)
Association between antipsychotic-induced metabolic side-effects and clinical improvement: A review on the Evidence for metabolic threshold''
Eesha Sharma et al.
ASIAN JOURNAL OF PSYCHIATRY (2014)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
Relationships between serum leptin level and severity of positive symptoms in schizophrenia
Yoichiro Takayanagi et al.
NEUROSCIENCE RESEARCH (2013)
An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis
Ofer Agid et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
The association between weight change and symptom reduction in the CATIE schizophrenia trial
Eric Hermes et al.
SCHIZOPHRENIA RESEARCH (2011)
The procognitive effects of leptin in the brain and their clinical implications
G. Paz-Filho et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation
S. Leucht et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Schizophrenia, just the facts 4. Clinical features and conceptualization
Rajiv Tandon et al.
SCHIZOPHRENIA RESEARCH (2009)
Leptin Replacement Improves Cognitive Development
Gilberto J. Paz-Filho et al.
PLOS ONE (2008)
Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
Othman Sentissi et al.
SCHIZOPHRENIA BULLETIN (2008)
Insulin and insulin-like growth factor-1 abnormalities in anti psychotic-naive schizophrenia
Ganesan Venkatasubramanian et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia
Umit B. Semiz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia
Xiaoduo Fan et al.
SCHIZOPHRENIA RESEARCH (2006)
Effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia
BB Kivircik et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Clozapine-induced weight gain predicts improvement in psychopathology
HY Meltzer et al.
SCHIZOPHRENIA RESEARCH (2003)
Insulin and leptin levels in patients with schizophrenia or related psychoses - a comparison between different antipsychotic agents
KI Melkersson et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
